AUG 4, 2026 · JOURNAL ARTICLE
Comparative immunogenicity of mRNA-1273 and BNT162b2 SARS-CoV-2 bivalent booster vaccines in US nursing home residents.
Human Vaccines & Immunotherapeutics
A sound comparative immunogenicity study in a vulnerable population showing equivalent responses between two widely used vaccines, but limited by cross-sectional design, surrogate endpoints, and lack of clinical outcome data.
Reported
Sampling window post-vaccination10-30 d